Methylprednisolone Sodium Succinate Injection, Powder, Lyophilized, For Solution
Product Images NDC 82094-404

11 FDA label images from Tianjin Kingyork Pharmaceuticals Co., Ltd · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Methylprednisolone Sodium Succinate (NDC 82094-404). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tianjin Kingyork Pharmaceuticals Co., Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Msssf)

Formula (Msssf)
Chemical structure of Methylprednisolone Sodium Succinate, showing the steroid backbone with hydroxyl, methyl, and sodium succinate ester functional groups.*
FDA Label Image

40 Container Label (Mss40mgvial)

40 Container Label (Mss40mgvial)
Label for Methylprednisolone Sodium Succinate Injection, USP, 40 mg per vial, lyophilized powder for reconstitution. For intramuscular or intravenous use, single-dose vial. Manufactured by Tianjin Kingyork Pharmaceuticals Co., Ltd. The label includes reconstitution instructions and a caution to protect from light.*
FDA Label Image

40 Carton Label (Mss40mgcarton1)

40 Carton Label (Mss40mgcarton1)
Packaging label for Methylprednisolone Sodium Succinate for Injection, USP 40 mg per vial, a lyophilized powder for injection. The label indicates 25 single dose vials, for intramuscular or intravenous use only. The product is manufactured by Tianjin Kingyork Pharmaceuticals Co., Ltd. The label includes storage instructions, usage directions, and notes that the package does not contain diluent, with benzyl alcohol as a preservative.*
FDA Label Image

125 Container Label (Mss125mgvial)

125 Container Label (Mss125mgvial)
Label for Methylprednisolone Sodium Succinate for Injection, USP, 125 mg per vial as lyophilized powder for injection. The product is for intramuscular or intravenous use, single dose vial with unused portion discarded. Manufactured by Tianjin Kingyork Pharmaceuticals Co., Ltd. The label includes reconstitution instructions and storage advice to protect from light.*
FDA Label Image

125 Carton Label (Mss125mgcarton1)

125 Carton Label (Mss125mgcarton1)
The packaging label for Methylprednisolone Sodium Succinate Injection, USP, 125 mg per vial, in lyophilized powder form for intramuscular or intravenous use. The box contains 25 single-dose vials and is manufactured by Tianjin Kingyork Pharmaceuticals Co., Ltd. The label includes storage instructions, usage notes, and a clear indication that the product is Rx only.*
FDA Label Image

500 Container Label (Mss500mgvial)

500 Container Label (Mss500mgvial)
Label for Methylprednisolone Sodium Succinate injection, USP, 500 mg per vial, lyophilized powder for solution. The product is for intramuscular or intravenous use, supplied in a multi-dose vial. It is manufactured by Tianjin Kingyork Pharmaceuticals Co., Ltd (Tianjin, China). The label includes instructions for reconstitution with 8 mL Bacteriostatic Water for Injection and storage conditions at controlled room temperature (20° to 25°C).*
FDA Label Image

500 Carton Label (Mss500mgcarton)

500 Carton Label (Mss500mgcarton)
Packaging label for Methylprednisolone Sodium Succinate Injection, USP 500 mg per vial, lyophilized powder for injection. Indicated for intramuscular or intravenous use only. Multi-dose vial with instructions to store at controlled room temperature 20° to 25°C and protect from light. Manufactured by Tianjin Kingyork Pharmaceuticals Co., Ltd (Tianjin, China). Label includes dosage information and cautions the package does not contain diluent, which contains benzyl alcohol as a preservative.*
FDA Label Image

1 Container Label (Mss1gvial)

1 Container Label (Mss1gvial)
Label for Methylprednisolone Sodium Succinate for Injection, USP, 1 g per vial, lyophilized powder for solution. Intended for intramuscular or intravenous use only. Multi-dose vial labeled for prescription use and manufactured by Tianjin Kingyork Pharmaceuticals Co., Ltd. Instructions include reconstitution with 16 mL Bacteriostatic Water containing Benzyl Alcohol as preservative, with storage and usage guidance.*
FDA Label Image

1 Carton Label (Mss1gcarton)

1 Carton Label (Mss1gcarton)
Packaging label for Methylprednisolone Sodium Succinate injection, USP, 1 g per vial, lyophilized powder for solution, intended for intramuscular or intravenous use. The label notes that the vial is multi-dose and that the package does not contain the recommended diluent which contains benzyl alcohol as a preservative. The product is manufactured by Tianjin Kingyork Pharmaceuticals Co., Ltd (Tianjin, China). Storage instructions and dosing cautions are included on the label.*
FDA Label Image

2 Container Label (Mss2gvial)

2 Container Label (Mss2gvial)
Label for Methylprednisolone Sodium Succinate for Injection, USP 2 g per vial, lyophilized powder for injection by intramuscular or intravenous use. The single-dose vial requires reconstitution with 30 mL bacteriostatic water for injection containing benzyl alcohol. Manufactured by Tianjin Kingyork Pharmaceuticals Co., Ltd (China).*
FDA Label Image

2 Carton Label (Mss2gcarton)

2 Carton Label (Mss2gcarton)
Label for Methylprednisolone Sodium Succinate Injection, USP 2 g per vial, lyophilized powder for solution, for intramuscular or intravenous use. The label includes storage instructions, dosing information cautioning that the package does not contain diluent, and notes single-dose vial with discard of unused portion. Manufactured by Tianjin Kingyork Pharmaceuticals Co., Ltd (Tianjin, China).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.